Accelerated Aging and Clearance of Host Anti-inflammatory Enzymes by Discrete Pathogens Fuels Sepsis
Overview
Microbiology
Authors
Affiliations
Sepsis is a life-threatening inflammatory syndrome accompanying a bloodstream infection. Frequently secondary to pathogenic bacterial infections, sepsis remains difficult to treat as a singular disease mechanism. We compared the pathogenesis of murine sepsis experimentally elicited by five bacterial pathogens and report similarities among host responses to Gram-negative Salmonella and E. coli. We observed that a host protective mechanism involving de-toxification of lipopolysaccharide by circulating alkaline phosphatase (AP) isozymes was incapacitated during sepsis caused by Salmonella or E. coli through activation of host Toll-like receptor 4, which triggered Neu1 and Neu3 neuraminidase induction. Elevated neuraminidase activity accelerated the molecular aging and clearance of AP isozymes, thereby intensifying disease. Mice deficient in the sialyltransferase ST3Gal6 displayed increased disease severity, while deficiency of the endocytic lectin hepatic Ashwell-Morell receptor was protective. AP augmentation or neuraminidase inhibition diminished inflammation and promoted host survival. This study illuminates distinct routes of sepsis pathogenesis, which may inform therapeutic development.
Molecular profiles of blood from numerous species that differ in sensitivity to acute inflammation.
Gregory D, Han F, Li P, Gritsenko M, Kyle J, Riley F Mol Med. 2024; 30(1):280.
PMID: 39730996 PMC: 11681734. DOI: 10.1186/s10020-024-01052-x.
Glycoproteomic profile of human tissue-nonspecific alkaline phosphatase expressed in osteoblasts.
Atanasova D, Mirgorodskaya E, Moparthi L, Koch S, Haarhaus M, Narisawa S JBMR Plus. 2024; 8(2):ziae006.
PMID: 38505526 PMC: 10945725. DOI: 10.1093/jbmrpl/ziae006.
Multi-Omic blood analysis reveals differences in innate inflammatory sensitivity between species.
Gregory D, Han F, Li P, Gritsenko M, Kyle J, Riley F medRxiv. 2023; .
PMID: 38076828 PMC: 10705660. DOI: 10.1101/2023.11.30.23299243.
Xiao Y, Yuan Y, Yang Y, Liu B, Ding Z, Luo J Inflamm Res. 2023; 72(10-11):1941-1955.
PMID: 37735250 DOI: 10.1007/s00011-023-01785-1.
Heithoff D, Barnes V L, Mahan S, Fried J, Fitzgibbons L, House J Cell Rep Med. 2023; 4(5):101023.
PMID: 37116500 PMC: 10213814. DOI: 10.1016/j.xcrm.2023.101023.